Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Put/Call Ratio
Increase
Decrease
Funds Holding
3,005
Funds Holding Change
+117
Funds Holding Growth
+4%
Value
$885B
Holding in Top 10
1,179
Top 10 Change
-94
Top 10 Growth
-7%
Value Growth
-5%
New
253
Increased
1,172
Reduced
1,419
Closed
75
Capital Inflow
$33.3B
Capital Outflow
$33.2B
Net Capital Flow
+$104M
Capital Flow Change
+$5.75B
Calls
$12.1B
Puts
$14.2B
Net Calls
-$2.1B
Put/Call Ratio
1.17